Indication

Hidradenitis suppurativa

Hidradenitis suppurativa is a chronic, recurrent inflammatory skin condition characterized by follicular occlusion and immune-mediated inflammation within apocrine gland–bearing areas. Read more about Hidradenitis suppurativa

117 drugs 22 manufacturers

Advertisement

Drugs that treat it

Common Hidradenitis suppurativa therapies.

Showing 91–99 of 117 drugs

Filter & compare in the drug finder →Opens the drug finder with Hidradenitis suppurativa preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hidradenitis suppurativa.

Hidradenitis suppurativa is a chronic, recurrent inflammatory skin condition characterized by follicular occlusion and immune-mediated inflammation within apocrine gland–bearing areas.

It primarily affects postpubertal individuals—most commonly young adult women—and typically manifests in intertriginous body sites such as the axillae, inguinal creases, perineum, and inframammary folds.

Pathophysiologically, hyperkeratosis leads to follicular occlusion, rupture, and subsequent tissue inflammation, producing painful deep-seated nodules, abscesses, draining sinus tracts, and extensive fibrotic scarring.

Personalize your experience

Follow Hidradenitis suppurativa and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it